SEARCH

SEARCH BY CITATION

References

  • Albaugh V. L., Henry C. R., Bello N. T., Hajnal A., Lynch S. L., Halle B. and Lynch C. J. (2006) Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) 14, 3651.
  • Albaugh V. L., Judson J. G., She P., Lang C. H., Maresca K. P., Joyal J. L. and Lynch C. J. (2011) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol. Psychiatry 16, 569581.
  • Albaugh V. L., Vary T. C., Ilkayeva O., Wenner B. R., Maresca K. P., Joyal J. L., Breazeale S., Elich T. D., Lang C. H. and Lynch C. J. (2012) Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophr. Bull. 38, 153166.
  • Baldessarini R. J., Centorrino F., Flood J. G., Volpicelli S. A., Huston-Lyons D. and Cohen B. M. (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9, 117124.
  • Basselin M., Chang L., Bell J. M. and Rapoport S. I. (2006) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31, 16591674.
  • Basselin M., Villacreses N. E., Lee H. J., Bell J. M. and Rapoport S. I. (2007) Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J. Neurochem. 102, 761772.
  • Basselin M., Kim H. W., Chen M., Ma K., Rapoport S. I., Murphy R. C. and Farias S. E. (2010) Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J. Lipid Res. 51, 10491056.
  • Bazinet R. P., Lee H. J., Felder C. C., Porter A. C., Rapoport S. I. and Rosenberger T. A. (2005a) Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30, 597601.
  • Bazinet R. P., Rao J. S., Chang L., Rapoport S. I. and Lee H. J. (2005b) Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacology 182, 180185.
  • Bazinet R. P., Rao J. S., Chang L., Rapoport S. I. and Lee H. J. (2006) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 59, 401407.
  • Bhattacharjee A. K., Chang L., Lee H. J., Bazinet R. P., Seemann R. and Rapoport S. I. (2005) D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology 180, 735742.
  • Bosetti F., Rintala J., Seemann R., Rosenberger T. A., Contreras M. A., Rapoport S. I. and Chang M. C. (2002) Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol. Psychiatry 7, 845850.
  • Bosetti F., Weerasinghe G. R., Rosenberger T. A. and Rapoport S. I. (2003) Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J. Neurochem. 85, 690696.
  • Bowden C. L., Calabrese J. R., McElroy S. L. et al. (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group. Arch. Gen. Psychiatry 57, 481489.
  • Calabrese J. R., Kimmel S. E., Woyshville M. J., Rapport D. J., Faust C. J., Thompson P. A. and Meltzer H. Y. (1996) Clozapine for treatment-refractory mania. Am. J. Psychiatry 153, 759764.
  • Calabrese J. R., Bowden C. L., Sachs G. et al. (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64, 10131024.
  • Chang M. C., Grange E., Rabin O., Bell J. M., Allen D. D. and Rapoport S. I. (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220, 171174.
  • Chang M. C., Contreras M. A., Rosenberger T. A., Rintala J. J., Bell J. M. and Rapoport S. I. (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J. Neurochem. 77, 796803.
  • Cheon Y., Park J. Y., Modi H. R., Kim H. W., Lee H. J., Chang L., Rao J. S. and Rapoport S. I. (2011) Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain. J. Neurochem. 119, 364376.
  • Cipriani A., Rendell J. and Geddes J. R. (2010) Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. J. Psychopharmacol. 24, 17291738.
  • Cooper G. D., Harrold J. A., Halford J. C. and Goudie A. J. (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 428436.
  • DeGeorge J. J., Noronha J. G., Bell J., Robinson P. and Rapoport S. I. (1989) Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 24, 413423.
  • Demar J. C. Jr, Ma K., Chang L., Bell J. M. and Rapoport S. I. (2005) alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94, 10631076.
  • DeMar J. C. Jr, Lee H. J., Ma K., Chang L., Bell J. M., Rapoport S. I. and Bazinet R. P. (2006) Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761, 10501059.
  • Deutsch J., Grange E., Rapoport S. I. and Purdon A. D. (1994) Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. Anal. Biochem. 220, 321323.
  • Deutsch J., Rapoport S. I. and Purdon A. D. (1997) Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22, 759765.
  • Duncan R. E., Sarkadi-Nagy E., Jaworski K., Ahmadian M. and Sul H. S. (2008) Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). J. Biol. Chem. 283, 2542825436.
  • Farde L. and Nordstrom A. L. (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br. J. Psychiatry Suppl. 17, 3033.
  • Fell M. J., Anjum N., Dickinson K., Marshall K. M., Peltola L. M., Vickers S., Cheetham S. and Neill J. C. (2007) The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology 194, 221231.
  • Ferno J., Vik-Mo A. O., Jassim G. et al. (2009) Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology 203, 7384.
  • Folch J., Lees M. and Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497509.
  • Frye M. A., Ketter T. A., Altshuler L. L., Denicoff K., Dunn R. T., Kimbrell T. A., Cora-Locatelli G. and Post R. M. (1998) Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J. Affect. Disord. 48, 91104.
  • Gavino V. C. and Gavino G. R. (1992) Adipose hormone-sensitive lipase preferentially releases polyunsaturated fatty acids from triglycerides. Lipids 27, 950954.
  • Geddes J. R., Goodwin G. M., Rendell J., Azorin J. M., Cipriani A., Ostacher M. J., Morriss R., Alder N. and Juszczak E. (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375, 385395.
  • Ghelardoni S., Tomita Y. A., Bell J. M., Rapoport S. I. and Bosetti F. (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry 56, 248254.
  • Ghelardoni S., Bazinet R. P., Rapoport S. I. and Bosetti F. (2005) Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism. Psychopharmacology 180, 523529.
  • Greil W., Ludwig-Mayerhofer W., Erazo N. et al. (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders–a randomised study. J. Affect. Disord. 43, 151161.
  • Halim N. D., Weickert C. S., McClintock B. W., Weinberger D. R. and Lipska B. K. (2004) Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29, 10631069.
  • Hegerl U. (2012) Review: risperidone, olanzapine and haloperidol are the most effective drugs for acute mania in adults with bipolar I disorder. Evid. Based Ment. Health 15, 45.
  • Holman R. T. (1986) Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5, 183211.
  • Igarashi M., Ma K., Chang L., Bell J. M., Rapoport S. I. and DeMar J. C., Jr (2006) Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet. J. Lipid Res. 47, 18121822.
  • Igarashi M., Ma K., Gao F., Kim H. W., Greenstein D., Rapoport S. I. and Rao J. S. (2010) Brain lipid concentrations in bipolar disorder. J. Psychiatr. Res. 44, 177182.
  • Janowsky A., Neve K. A., Kinzie J. M., Taylor B., de Paulis T. and Belknap J. K. (1992) Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine. J. Pharmacol. Exp. Ther. 261, 12821290.
  • Jutila A., Soderlund T., Pakkanen A. L., Huttunen M. and Kinnunen P. K. (2001) Comparison of the effects of clozapine, chlorpromazine, and haloperidol on membrane lateral heterogeneity. Chem. Phys. Lipids 112, 151163.
  • Kabbani N. and Levenson R. (2006) Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. NeuroReport 17, 299301.
  • Kaddurah-Daouk R., McEvoy J., Baillie R. A., Lee D., Yao J. K., Doraiswamy P. M. and Krishnan K. R. (2007) Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol. Psychiatry 12, 934945.
  • Kim H. W., Rapoport S. I. and Rao J. S. (2010) Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol. Dis. 37, 596603.
  • Kim H. W., Rao J. S., Rapoport S. I. and Igarashi M. (2011a) Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. Biochim. Biophys. Acta 1811, 111117.
  • Kim H. W., Rapoport S. I. and Rao J. S. (2011b) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol. Psychiatry 16, 419428.
  • Kim H. W., Cheon Y., Modi H. R., Rapoport S. I. and Rao J. S. (2012) Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain. Psychopharmacology 222, 663674.
  • Kirkilionis M. (2010) Exploration of cellular reaction systems. Brief. Bioinform. 11, 153178.
  • Kontkanen O., Lakso M., Wong G. and Castren E. (2002) Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27, 152162.
  • Kushner S. F., Khan A., Lane R. and Olson W. H. (2006) Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord. 8, 1527.
  • Lee H. J., Gheraldoni S., Chang L., Bosetti F., Rapoport S. I. and Bazinet R. P. (2005) Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of unanesthetized rats. Neurochem. Res. 30, 677683.
  • Lee H. J., Rao J. S., Chang L., Rapoport S. I. and Bazinet R. P. (2008) Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J. Lipid Res. 49, 162168.
  • Lee H. J., Rao J. S., Chang L., Rapoport S. I. and Kim H. W. (2010) Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder? Mol. Psychiatry 15, 602614.
  • Levant B., Crane J. F. and Carlson S. E. (2006) Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 728732.
  • Lidow M. S. and Goldman-Rakic P. S. (1997) Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J. Pharmacol. Exp. Ther. 283, 939946.
  • Meshul C. K., Bunker G. L., Mason J. N., Allen C. and Janowsky A. (1996) Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. J. Neurochem. 67, 19651973.
  • Minet-Ringuet J., Even P. C., Lacroix M., Tome D. and de Beaurepaire R. (2006) A model for antipsychotic-induced obesity in the male rat. Psychopharmacology 187, 447454.
  • Modi H. R., Cheon Y., Kim H. W., Chang L., Rao J. S. and Rapoport S. I. (2011) Effect of chronic administration of clozapine on arachidonic acid (AA) turnover. Society of Biological Psychiatry 66th Annual Meeting 2011, 12–14 May 2011, 740.
  • Ossowska K., Pietraszek M., Wardas J., Dziedzicka-Wasylewska M., Nowicka D. and Wolfarth S. (2002) Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study. Pol. J. Pharmacol. 54, 19.
  • Parry M. J., Alakoskela J. M., Khandelia H., Kumar S. A., Jaattela M., Mahalka A. K. and Kinnunen P. K. (2008) High-affinity small molecule-phospholipid complex formation: binding of siramesine to phosphatidic acid. J. Am. Chem. Soc. 130, 1295312960.
  • Piomelli D. and Di Marzo V. (1993) Dopamine D2 receptor signaling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2. J. Lipid Mediat. 6, 433443.
  • Purdon D., Arai T. and Rapoport S. (1997) No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J. Lipid Res. 38, 526530.
  • Raclot T. (2003) Selective mobilization of fatty acids from adipose tissue triacylglycerols. Prog. Lipid Res. 42, 257288.
  • Ramadan E., Basselin M., Taha A. Y., Cheon Y., Chang L., Chen M. and Rapoport S. I. (2011) Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats. Neuropharmacology 61, 12561264.
  • Rao J. S., Harry G. J., Rapoport S. I. and Kim H. W. (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 15, 384392.
  • Rao J. S., Kellom M., Reese E. A., Rapoport S. I. and Kim H. W. (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 136, 6371.
  • Rapoport S. I., Fitzhugh R., Pettigrew K. D., Sundaram U. and Ohno K. (1982) Drug entry into and distribution within brain and cerebrospinal fluid: 14C-urea pharmacokinetics. Amer. J. Physiol. 242, R339R348.
  • Rapoport S. I. (2008) Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids 79, 153156.
  • Rapoport S. I. and Bosetti F. (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. Gen. Psychiatry 59, 592596.
  • Rapoport S. I., Basselin M., Kim H. W. and Rao J. S. (2009) Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res. Rev. 61, 185209.
  • Robinson P. J., Noronha J., DeGeorge J. J., Freed L. M., Nariai T. and Rapoport S. I. (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17, 187214.
  • Scherk H., Pajonk F. G. and Leucht S. (2007) Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch. Gen. Psychiatry 64, 442455.
  • Shimizu T. and Wolfe L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 115.
  • Shimshoni J. A., Basselin M., Li L. O., Coleman R. A., Rapoport S. I. and Modi H. R. (2011) Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder. Biochim. Biophys. Acta 1811, 163169.
  • Silvestri S., Seeman M. V., Negrete J. C. et al. (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152, 174180.
  • Skipski V. P., Barclay M., Reichman E. S. and Good J. J. (1967) Separation of acidic phospholipids by one-dimensional thin-layer chromatography. Biochim. Biophys. Acta 137, 8089.
  • Skipski V. P., Good J. J., Barclay M. and Reggio R. B. (1968) Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta 152, 1019.
  • Soderlund T., Jutila A. and Kinnunen P. K. (1999) Binding of adriamycin to liposomes as a probe for membrane lateral organization. Biophys. J . 76, 896907.
  • Sun G. Y. and MacQuarrie R. A. (1989) Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N. Y. Acad. Sci. 559, 3755.
  • Tarazi F. I., Florijn W. J. and Creese I. (1997) Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Neuroscience 78, 985996.
  • Thambisetty M., Gallardo K. A., Liow J. S. et al. (2012) The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans. J. Cereb. Blood Flow Metab. 32, 676684.
  • Tulipano G., Rizzetti C., Bianchi I., Fanzani A., Spano P. and Cocchi D. (2007) Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation. Neuroendocrinology 85, 6170.
  • Vidarsdottir S., de Leeuw van Weenen J. E., Frolich M., Roelfsema F., Romijn J. A. and Pijl H. (2010) Effects of olanzapine and haloperidol on the metabolic status of healthy men. J. Clin. Endocrinol. Metab. 95, 118125.
  • Washizaki K., Smith Q. R., Rapoport S. I. and Purdon A. D. (1994) Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63, 727736.
  • Zarate C. A. Jr, Tohen M. and Baldessarini R. J. (1995) Clozapine in severe mood disorders. J. Clin. Psychiatry 56, 411417.